$7.5 million isn't much money (in the grand scheme of things), but maybe they are just taking what they can get at this point. I'm definitely looking for an entry point. I'd prefer they go it alone, just to maximize returns for me, but more likely a partnership or buyout is in their future. Dirt cheap for one of the big biotechs. Maybe that's why they lowered the AS so substantially? Maybe that's why they just need the $7.5 million to get them by a little longer?
News 
Market Data 
Discover 
